Analgesic effects of clinically used compounds in novel mouse models of polyneuropathy induced by oxaliplatin and cisplatin
Jennifer R. Deuis(The University of Queensland), Irina Vetter(Centre National de la Recherche Scientifique), Yah Leng Lim(The University of Queensland), Paul F. Alewood(The University of Queensland), Peter J. Cabot(The University of Queensland), Silmara Rodrigues de Sousa(The University of Queensland), Richard J. Lewis(AstraZeneca (Netherlands))
Cited by 48
Related Papers
A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases
|Nature Medicine|2015|2.8k
Methods Used to Evaluate Pain Behaviors in Rodents
|Frontiers in Molecular Neuroscience|2017|1.3k
Therapeutic potential of venom peptides
|Nature Reviews Drug Discovery|2003|786
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
|Frontiers in Molecular Neuroscience|2017|654
Conus Venom Peptide Pharmacology
|Pharmacological Reviews|2012|422